<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin J Gastroenterol</journal-id><journal-id journal-id-type="iso-abbrev">Clin J Gastroenterol</journal-id><journal-title-group><journal-title>Clinical Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="ppub">1865-7257</issn><issn pub-type="epub">1865-7265</issn><publisher><publisher-name>Springer Nature Singapore</publisher-name><publisher-loc>Singapore</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39614950</article-id><article-id pub-id-type="pmc">PMC11785620</article-id>
<article-id pub-id-type="publisher-id">2075</article-id><article-id pub-id-type="doi">10.1007/s12328-024-02075-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>A case of malignant lymphoma of the extrahepatic bile duct diagnosed by detailed imaging examination and endoscopic ultrasound-guided fine needle aspiration</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Iijima</surname><given-names>Noriaki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Shinya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3545-8743</contrib-id><name><surname>Ishii</surname><given-names>Yasutaka</given-names></name><address><email>yishii@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tatsukawa</surname><given-names>Yumiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ikemoto</surname><given-names>Juri</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Miyamoto</surname><given-names>Sayaka</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Nakamura</surname><given-names>Kazuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Furukawa</surname><given-names>Masaru</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arihiro</surname><given-names>Koji</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Oka</surname><given-names>Shiro</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03t78wx29</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution>Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, </institution><institution>Hiroshima University, </institution></institution-wrap>1-2-3 Kasumi, Minami-Ku, Hiroshima, 734-8551 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/038dg9e86</institution-id><institution-id institution-id-type="GRID">grid.470097.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0618 7953</institution-id><institution>Department of Pathology, </institution><institution>Hiroshima University Hospital, </institution></institution-wrap>Hiroshima, Japan </aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>18</volume><issue>1</issue><fpage>176</fpage><lpage>182</lpage><history><date date-type="received"><day>18</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">A 70-year-old woman presented to our hospital with abdominal pain. Imaging examinations showed diffuse and extensive wall thickening at the perihilar bile duct; however, the degree of stricture was mild, and the mucosal epithelium was smooth. A transpapillary biopsy was performed considering cholangiocarcinoma and IgG4 sclerosing cholangitis as differential diagnoses; however, no pathologic diagnosis was obtained. Peroral cholangioscopy revealed a regular epithelium at the stricture, and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of the enlarged lymph node confirmed the diagnosis of diffuse large B-cell lymphoma. Multiagent chemotherapy was administered, which led to complete remission. Because primary bile duct malignant lymphomas are rare and specific, clinical, and imaging findings are lacking, and many of those reported so far have been diagnosed by postoperative pathology. As chemotherapy is the first-line treatment for malignant lymphoma, obtaining an accurate diagnosis is crucial. Our findings support that smooth and mild biliary strictures with mainly submucosal wall thickening may be characteristic imaging findings of primary bile duct malignant lymphoma, and that peroral cholangioscopy and EUS-FNA may be helpful for an accurate diagnosis.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s12328-024-02075-x.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Malignant lymphoma</kwd><kwd>Diffuse large B-cell lymphoma</kwd><kwd>Bile duct</kwd><kwd>Endoscopic retrograde cholangiopancreatography</kwd><kwd>Endoscopic ultrasound-guided fine-needle aspiration</kwd></kwd-group><funding-group><award-group><funding-source><institution>Hiroshima University</institution></funding-source></award-group><open-access><p>Open Access funding provided by Hiroshima University.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Japanese Society of Gastroenterology 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Malignant lymphoma (ML) is known to occur not only in the lymph nodes but also in various other organs, the most common extranodal organs of which are the gastrointestinal tract lesions [<xref ref-type="bibr" rid="CR1">1</xref>]. ML causes bile duct stricture in 1&#x02013;2% of all cases [<xref ref-type="bibr" rid="CR2">2</xref>]; however, the main cause of stricture is extrinsic invasion of adjacent organs or compression by peribiliary lymph nodes, and primary bile duct ML is rare. Owing to its rarity, the imaging findings of bile duct ML are not readily available. Moreover, obtaining a sufficient amount of tissue via biopsy is a challenge [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, the accurate diagnosis of bile duct ML is challenging, and many of the reported cases were resected with a diagnosis of cholangiocarcinoma and diagnosed as ML postoperatively [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. Herein, we report a case of ML of the extrahepatic bile duct diagnosed using detailed imaging examination and endoscopic ultrasound-guided fine needle aspiration (EUS-FNA).</p></sec><sec id="Sec2"><title>Case report</title><p id="Par3">A 70-year-old woman presented to our hospital complaining of epigastric pain for one month. She had a medical history of hypertension, arterial fibrillation, bronchial asthma, and chronic renal failure. She had no specific family history or history of alcohol consumption or smoking. Physical examination revealed no jaundice, and no superficial lymph nodes were palpable. Laboratory findings (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) showed mild elevation of hepatobiliary enzymes but no elevation of tumor markers (i.e., carcinoembryonic antigen, carbohydrate antigen 19&#x02013;9, and soluble interleukin-2 receptor [sIL-2R]). Contrast-enhanced computed tomography revealed mild intrahepatic bile duct dilatation, bile duct wall thickening in the perihilar region (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a), and a 20-mm mass adjacent to the thickened bile duct (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). No other abnormal findings were observed in the imaging range from the chest to the pelvis. Magnetic resonance imaging revealed a thickened wall of the perihilar bile duct and the adjacent mass had a hyperintense signal on diffusion-weighted imaging (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). Magnetic resonance cholangiopancreatography revealed a stricture in the bile duct extending from the hepatic hilum to the vicinity of the confluence of the cystic duct, and the upstream bile duct was slightly dilated (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b). Endoscopic ultrasonography revealed a thickened bile duct wall as much as 8-mm in diameter with smooth internal echoes (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a) and a proper hepatic artery with a preserved lumen penetrating the wall (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b). A 2-cm mass, found close to the lesion, was considered an enlarged lymph node. The boundary between the bile duct and mass was clear, and no continuity was observed (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c). Endoscopic retrograde cholangiopancreatography (ERCP) revealed a relatively extensive and gently rising stricture in the perihilar bile duct (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). Meanwhile, intraductal ultrasonography showed homogeneous wall thickening (3.5&#x000a0;mm) in the stenotic area (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b), but no wall thickening in the non-stenotic area (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). Peroral cholangioscopy (POCS) shows submucosal tumor-like-circumferential narrowing in the stenotic area, with mildly irregular and uneven but smooth mucosa, and no severe mucosal irregularities or unevenly dilated blood vessels suggestive of cholangiocarcinoma were observed (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b). In the non-stenotic area, POCS reveals no mucosal irregularity (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). Therefore, transpapillary bile cytology, brush cytology, and forceps biopsy were performed; however, a pathologic diagnosis could not be made. Therefore, EUS-FNA was performed on the enlarged lymph nodes using the echoendoscope (GF-UCT260; Olympus Medical Systems, Tokyo, Japan) and a 22-G needle (EZ Shot 3 plus; Olympus Medical Systems). Specimens were obtained from the duodenal bulb by two punctures using a standard 10-ml suction method. Diffuse proliferation of large atypical cells with anisotropic and irregular nuclei was observed in the biopsy specimens (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). Immunohistochemical staining was positive for CD10, CD20, and BCL6, and negative for CD3 and MUM-1 (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b&#x02013;f). These findings confirmed germinal center B-cell-like diffuse large B-cell lymphoma (DLBCL), according to the Hans&#x02019; algorithm [<xref ref-type="bibr" rid="CR8">8</xref>].<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Laboratory findings</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Hematology</th><th align="left"/><th align="left">Biochemistry</th><th align="left"/><th align="left"/><th align="left"/></tr></thead><tbody><tr><td align="left">WBC</td><td align="left">8700/&#x003bc;L</td><td align="left">T-Bil</td><td align="left">0.6&#x000a0;mg/dL</td><td align="left">IgG</td><td align="left">1017&#x000a0;mmol/L</td></tr><tr><td align="left">RBC</td><td align="left">496&#x02009;&#x000d7;&#x02009;10<sup>4</sup>/&#x003bc;L</td><td align="left">AST</td><td align="left">32 U/L</td><td align="left">IgG4</td><td align="left">43.1&#x000a0;mmol/L</td></tr><tr><td align="left">Hb</td><td align="left">14.9&#x000a0;g/dL</td><td align="left">ALT</td><td align="left">36 U/L</td><td align="left">Na</td><td align="left">136&#x000a0;mmol/L</td></tr><tr><td align="left">Ht</td><td align="left">44.7%</td><td align="left">LDH</td><td align="left">244 U/L</td><td align="left">K</td><td align="left">3.9&#x000a0;mmol/L</td></tr><tr><td align="left">Plt</td><td align="left">24&#x02009;&#x000d7;&#x02009;10<sup>4</sup>/&#x003bc;L</td><td align="left">ALP 347</td><td align="left">U/L</td><td align="left">Cl</td><td align="left">101&#x000a0;mmol/L</td></tr><tr><td align="left"/><td align="left"/><td align="left">r-GTP</td><td align="left">106 U/L</td><td align="left">CRP</td><td align="left">0.16&#x000a0;mg/dL</td></tr><tr><td align="left">Coagulation</td><td align="left"/><td align="left">AMY</td><td align="left">76 U/L</td><td align="left"/><td align="left"/></tr><tr><td align="left">PT</td><td align="left">124%</td><td align="left">BUN</td><td align="left">18.7&#x000a0;mg/dL</td><td align="left">Tumor markers</td><td align="left"/></tr><tr><td align="left">PT-INR</td><td align="left">0.88</td><td align="left">Cr</td><td align="left">1.24&#x000a0;mg/dL</td><td align="left">CEA</td><td align="left">2.8&#x000a0;ng/mL</td></tr><tr><td align="left">APTT</td><td align="left">27.3&#x000a0;s</td><td align="left">TP</td><td align="left">7.1&#x000a0;g/dL</td><td align="left">CA19-9</td><td align="left">2 U/mL</td></tr><tr><td align="left"/><td align="left"/><td align="left">Alb</td><td align="left">4.2&#x000a0;g/dL</td><td align="left">sIL-2R</td><td align="left">562 U/mL</td></tr><tr><td align="left"/><td align="left"/><td align="left">T-Chol</td><td align="left">256&#x000a0;mg/dL</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left">TG</td><td align="left">76&#x000a0;mg/dL</td><td align="left"/><td align="left"/></tr></tbody></table><table-wrap-foot><p>WBC, white blood cells; RBC, red blood cells; Hb, hemoglobin; Ht, hematocrit; Plt, platelets; PT, prothrombin time; PT-INR, prothrombin time-international normalized ratio; APTT, activated partial thromboplastin time; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; &#x003b3;-GTP, &#x003b3;-glutamyl transpeptidase; AMY, amylase; BUN, blood urea nitrogen; Cr, creatinine; TP, total protein; Alb, albumin; T-Chol, total cholesterol; TG, triglyceride; IgG, immunoglobulin G; IgG4, immunoglobulin G4; CRP, c-reactive protein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19&#x02013;9; sIL-2R, soluble interleukin-2 receptor</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Contrast-enhanced computed tomography. <bold>a</bold> Image depicting thickening of the perihilar bile duct wall with contrast enhancement (arrow). <bold>b</bold> Image of an enlarged lymph node next to the perihilar bile duct (arrow)</p></caption><graphic xlink:href="12328_2024_2075_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Magnetic resonance imaging. <bold>a</bold> The thickened wall of the perihilar bile duct and adjacent mass shows a hyperintense signal on diffusion-weighted imaging (arrow). <bold>b</bold> Magnetic resonance cholangiopancreatography reveals stricture of the bile duct from the hepatic hilum to the vicinity of the confluence of the cystic duct (arrow), and the upstream bile duct is slightly dilated</p></caption><graphic xlink:href="12328_2024_2075_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Endoscopic ultrasonography. <bold>a</bold> The thickened bile duct shows a smooth inner border echo. <bold>b</bold> The lumen of proper hepatic artery penetrating the thickened wall is preserved. <bold>c</bold> A 2-cm mass (arrow) is found close to the lesion, which is considered an enlarged lymph node. The boundary between the bile duct and the mass is clear and no continuity is observed</p></caption><graphic xlink:href="12328_2024_2075_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Endoscopic retrograde cholangiopancreatography. <bold>a</bold> A relatively extensive, gently rising stricture is observed in the perihilar bile duct (arrow). <bold>b</bold> In the stenotic area, intraductal ultrasonography reveals a homogeneous wall thickening of 3.5&#x000a0;mm and peroral cholangioscopy shows submucosal tumor-like-circumferential narrowing with mildly irregular and uneven but smooth mucosa, and no severe mucosal irregularities or unevenly dilated blood vessels suggestive of cholangiocarcinoma were observed. <bold>c</bold> In the non-stenotic area, intraductal ultrasonography reveals no wall thickening and peroral cholangioscopy shows no mucosal irregularity</p></caption><graphic xlink:href="12328_2024_2075_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Pathologic findings of endoscopic ultrasound-guided fine needle aspiration specimens. A diffuse proliferation of large, atypical cells with anisotropic, irregular nuclei is observed by hematoxylin and eosin staining (<bold>a</bold>). Immunohistochemical staining is positive for CD10 (<bold>b</bold>), CD20 (<bold>c</bold>), and BCL-6 (<bold>d</bold>) and negative for CD3 (<bold>e</bold>) and MUM-1 (<bold>f</bold>), consistent with diffuse large B-cell lymphoma, germinal center B-cell&#x02013;like subtype</p></caption><graphic xlink:href="12328_2024_2075_Fig5_HTML" id="MO5"/></fig></p><p id="Par4">Based on the diagnosis of DLBCL, the patient received six cycles of R-CHOP chemotherapy, comprising rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone, which resulted in complete remission. The abdominal pain resolved promptly after the initiation of treatment and was attributed to cholestasis caused by bile duct stricture. At 19&#x000a0;months post-diagnosis, the patient remained in complete remission (Fig. <xref rid="MOESM1" ref-type="media">S1</xref>a, b).</p></sec><sec id="Sec3"><title>Discussion</title><p id="Par5">Extranodal ML accounts for 20&#x02013;40% of all cases [<xref ref-type="bibr" rid="CR9">9</xref>]; the most common extranodal organs affected are along the gastrointestinal tract, including the stomach, small intestine, and colon [<xref ref-type="bibr" rid="CR1">1</xref>]. Biliary stricture and obstructive jaundice have been reported in 1&#x02013;2% of all cases, mostly as a result of compression of enlarged lymph nodes or invasion from adjacent organs [<xref ref-type="bibr" rid="CR2">2</xref>]. Since its first report by Nguyen in 1982 [<xref ref-type="bibr" rid="CR10">10</xref>], 52 cases of primary bile duct ML have been recorded [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>], including our case. According to these reports, 11 cases were diagnosed without surgery (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>], while others were diagnosed preoperatively with cholangiocarcinoma and therefore underwent surgical resection. Among the 52 reported cases of bile duct ML including our case, results of sIL-2R levels were available in only seven cases. Four of these (57%) did not exhibit elevated sIL-2R levels, and all were limited to the bile duct [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The remaining three cases with elevated sIL-2R levels had disease in multiple organs [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Although the small number of cases makes it difficult to draw definite conclusions, elevated sIL-2R levels may indicate the spread of disease.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Summary of reported cases of bile duct malignant lymphoma diagnosed without surgical resection</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Case</th><th align="left">Age/sex</th><th align="left">Location</th><th align="left">Tissue sampling methods</th><th align="left">Pathologic diagnosis</th><th align="left">Treatment</th><th align="left">Outcome</th></tr></thead><tbody><tr><td align="left">Corbinais [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">29/M</td><td align="left">Common bile duct</td><td align="left">ND</td><td align="left">HGTL</td><td align="left">COP plus CHOP</td><td align="left">Alive for 12&#x000a0;months</td></tr><tr><td align="left">Das [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">51/M</td><td align="left">Perihilar</td><td align="left">US-guided needle biopsy</td><td align="left">DLBCL</td><td align="left">R-CHOP</td><td align="left">Alive for 18&#x000a0;months</td></tr><tr><td align="left">Torrealba [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td align="left">69/M</td><td align="left">Distal</td><td align="left">Transpapillary biopsy (bile duct)</td><td align="left">MALT lymphoma</td><td align="left">Chemoradiation</td><td align="left">Unknown</td></tr><tr><td align="left">Ikuta [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td align="left">66/M</td><td align="left">Distal</td><td align="left">Transpapillary biopsy (bile duct, major papilla)</td><td align="left">MALT lymphoma</td><td align="left"><p>HPET</p><p>R-CHOP</p></td><td align="left">Recurrence at 12&#x000a0;months after HPET, PR after R-CHOP</td></tr><tr><td align="left">Durham [<xref ref-type="bibr" rid="CR13">13</xref>]</td><td align="left">61/M</td><td align="left">Perihilar</td><td align="left">Transpapillary biopsy (bile duct)</td><td align="left">HGBL</td><td align="left">R-CHOP</td><td align="left">Unknown</td></tr><tr><td align="left">Inoue [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">78/F</td><td align="left">Perihilar</td><td align="left">Transpapillary biopsy (bile duct)</td><td align="left">MALT lymphoma</td><td align="left">R-CVP</td><td align="left">CR for 12&#x000a0;months</td></tr><tr><td align="left">Ohtsubo [<xref ref-type="bibr" rid="CR11">11</xref>]</td><td align="left">67/F</td><td align="left">Perihilar</td><td align="left">Transpapillary biopsy (bile duct, major papilla)</td><td align="left">HGBL</td><td align="left"><p>R-CHOP</p><p>DA-EPOCH-R</p></td><td align="left">CR for 18&#x000a0;months</td></tr><tr><td align="left">Pararas [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td align="left">61/F</td><td align="left">Perihilar</td><td align="left">Diagnostic laparoscopy</td><td align="left">DLBCL</td><td align="left">R-CHOP</td><td align="left">No recurrence for 8&#x000a0;months</td></tr><tr><td align="left">Sakashita [<xref ref-type="bibr" rid="CR3">3</xref>]</td><td align="left">80/F</td><td align="left">Perihilar</td><td align="left">Transpapillary biopsy (bile duct)</td><td align="left">MALT lymphoma</td><td align="left">Rituximab</td><td align="left">No recurrence for 12&#x000a0;months</td></tr><tr><td align="left">Imai [<xref ref-type="bibr" rid="CR12">12</xref>]</td><td align="left">54/M</td><td align="left">Distal</td><td align="left">Transpapillary biopsy, EUS-FNA (bile duct)</td><td align="left">DLBCL</td><td align="left">R-CHOP</td><td align="left">No recurrence for 10&#x000a0;months</td></tr><tr><td align="left">Present case</td><td align="left">70/F</td><td align="left">Perihilar</td><td align="left">EUS-FNA (lymph node)</td><td align="left">DLBCL</td><td align="left">R-CHOP</td><td align="left">CR for 19&#x000a0;months</td></tr></tbody></table><table-wrap-foot><p>M, male; F, female; US, ultrasound; EUS-FNA, endoscopic ultrasound-fine needle aspiration; HGTL, high grade T-cell lymphoma; DLBCL, diffuse large B-cell lymphoma; MALT, mucosa-associated lymphoid tissue; HGBL, high grade B-cell lymphoma; COP, cyclophosphamide, oncovin and prednisone; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; HPET, <italic>Helicobacter pylori</italic>-eradication therapy; R-CVP, rituximab, cyclophosphamide, vincristine, and prednisone; DA-EPOCH-R rituximab, etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin; CR, complete remission, PR partial remission</p></table-wrap-foot></table-wrap></p><p id="Par6">Accurate diagnosis of bile duct ML is difficult, in part because imaging characteristics of bile duct ML are not well-known. Yoon et al. [<xref ref-type="bibr" rid="CR4">4</xref>] reported that the characteristic findings of primary bile duct ML were smooth, mild luminal narrowing of the extrahepatic bile duct without mucosal irregularity, despite diffuse thickening of the bile duct wall. In addition cholangioscopic findings of bile duct ML have only been reported in five cases, including ours [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Three lesions in the two cases of MALT lymphoma exhibited a nodular lesion with ulceration and increased vascularity, flat lesion, and flat-depressed lesion with increased vascularity. In contrast, three patients with DLBCL presented with submucosal tumor-like lesions showing circumferential narrowing, with no abnormal findings on the mucosal surface. These characteristics are continuous with those of primary gastrointestinal ML [<xref ref-type="bibr" rid="CR21">21</xref>]. Moreover, intestinal DLBCL, the most common histologic type of NHL, presents with a long circumferential stricture, while luminal extension is preserved, and passage is not easily impaired [<xref ref-type="bibr" rid="CR22">22</xref>]. The present case of DLBCL also presented a smooth stricture, which was mild compared with the degree of wall thickening. As these findings resemble those of IgG4-related sclerosing cholangitis (IgG4-SC) rather than cholangiocarcinoma, bile duct ML may also be considered in the differential diagnosis when IgG4-SC is suspected. The characteristic POCS findings of the stricture site of IgG4-SC are a smooth mucosal surface, lack of easy bleeding, and dilated tortuous vessels with less abrupt caliber alteration and disruption than those in extrahepatic cholangiocarcinoma [<xref ref-type="bibr" rid="CR23">23</xref>]. Our case concurs with the mucosal and bleeding findings but differs in the presence of dilated blood vessels, which may indicate a point of differentiation between bile duct ML and IgG4-SC; however, as there are few reported cases, further studies are warranted. Cholangiocarcinoma and primary sclerosing cholangitis (PSC) are also important in the differentiation of bile duct stricture. POCS findings of cholangiocarcinoma is characterized by irregularly dilated and tortuous vessels and an irregular papillrogranular surface [<xref ref-type="bibr" rid="CR24">24</xref>], while POCS findings of PSC is characterized by scarring and pseudodiverticula [<xref ref-type="bibr" rid="CR25">25</xref>]. In the present case, there was mild irregularity of the mucosa of the stricture, but no dilated vessels were present, nor were there any findings suggestive of PSC.</p><p id="Par7">Another reason for the difficulty in diagnosing bile duct ML is the limited collection of pathologic samples. Brush cytology with ERCP and transpapillary forceps biopsies are routinely used to diagnose biliary strictures. However, the sensitivities of brush cytology, forceps biopsy, brush cytology, and forceps biopsy were poor, at 41%, 52%, and 66%, respectively [<xref ref-type="bibr" rid="CR26">26</xref>], and many cases required surgery for the diagnosis of cholangiocarcinoma. In this case, a diagnosis could not be made by transpapillary biopsy. Although some cases of ML have been diagnosed through transpapillary biopsy (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), many cases of bile duct ML have been misdiagnosed as cholangiocarcinoma, leading to unnecessary surgery. This may be due to the submucosal location of lesions, as observed with POCS, making it difficult to obtain adequate samples through forceps biopsy. Recent reports highlight the usefulness of EUS-FNA in improving the diagnostic performance of bile duct lesions [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]. The sensitivity and specificity of EUS-FNA for bile duct lesions not diagnosed by ERCP have been reported to be 77&#x02013;89% and 100%, respectively [<xref ref-type="bibr" rid="CR27">27</xref>], and for enlarged lymph nodes, 94% and 100%, respectively [<xref ref-type="bibr" rid="CR28">28</xref>]. However, EUS-FNA of bile duct lesions poses potential risks, including biliary fistulas formation and needle-tract seeding [<xref ref-type="bibr" rid="CR29">29</xref>], warranting careful consideration before its application. In cases of bile duct strictures where transpapillary biopsy fails to provide a diagnosis, as in the present case, EUS-FNA targeting enlarged, accessible lymph nodes may be prioritized. Conversely, one case of bile duct ML has been reported wherein repeated transpapillary biopsy via ERCP and EUS-FNA, successfully confirmed bile duct ML [<xref ref-type="bibr" rid="CR12">12</xref>]. Thus, when a false-negative result is suspected, a short-term re-examination with transpapillary biopsy or EUS-FNA should be considered.</p><p id="Par8">In the present study, we encountered a case of ML of the extrahepatic bile duct, which had been diagnosed via detailed imaging examination and EUS-FNA. Diagnosing bile duct ML is challenging, and failure to achieve a diagnosis may necessitate highly invasive procedures, such as pancreaticoduodenectomy or hepatectomy. Utilizing both transpapillary biopsy and EUS-FNA, when necessary for a definitive diagnosis, could help prevent unnecessary surgeries and offer considerable benefits for patient outcomes. Our findings suggest that, when relatively extensive submucosal wall thickening and mild luminal narrowing without mucosal surface irregularities mimicking IgG4-SC are present, ML should be considered in the differential diagnosis. In addition, our report supports that POCS and EUS-FNA can contribute to an accurate diagnosis of bile duct ML.</p></sec><sec id="Sec4" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12328_2024_2075_MOESM1_ESM.jpg"><caption><p><bold>Fig</bold><bold>.</bold>
<bold>S1</bold> Image findings 19 months after initiation of treatment. a The bile duct wall thickening is improved in plane CT. b No significant 18-fluorodeoxyglucose uptake is observed. (JPG 1947 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors thank Editage (<ext-link ext-link-type="uri" xlink:href="http://www.editage.jp">www.editage.jp</ext-link>) for the English language editing.</p></ack><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by Hiroshima University.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par9">The authors declare no conflicts of interest.</p></notes><notes id="FPar2"><title>Human rights</title><p id="Par10">All procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its amendments.</p></notes><notes id="FPar3"><title>Informed consent</title><p id="Par11">The patient presented in this case report provided informed consent.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name></person-group><article-title>Gastrointestinal lymphoma: recent advances in diagnosis and treatment</article-title><source>Digestion</source><year>2013</year><volume>87</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1159/000350051</pub-id><pub-id pub-id-type="pmid">23635497</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013;87:182&#x02013;8.<pub-id pub-id-type="pmid">23635497</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>T</given-names></name></person-group><article-title>Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer</article-title><source>World J Gastroenterol</source><year>2022</year><volume>28</volume><fpage>985</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.3748/wjg.v28.i10.985</pub-id><pub-id pub-id-type="pmid">35431494</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Okamoto T. Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer. World J Gastroenterol. 2022;28:985&#x02013;1008.<pub-id pub-id-type="pmid">35431494</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Sakashita</surname><given-names>M</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Omizo</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bile duct MALT lymphoma diagnosed with direct cholangioscopy: a case report</article-title><source>Clin J Gastroenterol</source><year>2022</year><volume>15</volume><fpage>1145</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1007/s12328-022-01692-8</pub-id><pub-id pub-id-type="pmid">36053483</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Sakashita M, Matsuda K, Omizo T, et al. Bile duct MALT lymphoma diagnosed with direct cholangioscopy: a case report. Clin J Gastroenterol. 2022;15:1145&#x02013;50.<pub-id pub-id-type="pmid">36053483</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Primary biliary lymphoma mimicking cholangiocarcinoma: a characteristic feature of discrepant CT and direct cholangiography findings</article-title><source>J Korean Med Sci</source><year>2009</year><volume>24</volume><fpage>956</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.3346/jkms.2009.24.5.956</pub-id><pub-id pub-id-type="pmid">19794999</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Yoon MA, Lee JM, Kim SH, et al. Primary biliary lymphoma mimicking cholangiocarcinoma: a characteristic feature of discrepant CT and direct cholangiography findings. J Korean Med Sci. 2009;24:956&#x02013;9.<pub-id pub-id-type="pmid">19794999</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Zakaria</surname><given-names>A</given-names></name><name><surname>Al-Obeidi</surname><given-names>S</given-names></name><name><surname>Daradkeh</surname><given-names>S</given-names></name></person-group><article-title>Primary non-Hodgkin&#x02019;s lymphoma of the common bile duct: a case report and literature review</article-title><source>Asian J Surg</source><year>2017</year><volume>40</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.asjsur.2013.09.009</pub-id><pub-id pub-id-type="pmid">24239512</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Zakaria A, Al-Obeidi S, Daradkeh S. Primary non-Hodgkin&#x02019;s lymphoma of the common bile duct: a case report and literature review. Asian J Surg. 2017;40:81&#x02013;7.<pub-id pub-id-type="pmid">24239512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Primary biliary non-Hodgkin&#x02019;s lymphoma: a case report</article-title><source>Medicine</source><year>2021</year><volume>100</volume><fpage>e26110</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000026110</pub-id><pub-id pub-id-type="pmid">34087857</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Wu J, Zhou Y, Li Q, et al. Primary biliary non-Hodgkin&#x02019;s lymphoma: a case report. Medicine. 2021;100:e26110.<pub-id pub-id-type="pmid">34087857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DL</given-names></name><name><surname>Deschner</surname><given-names>BW</given-names></name><name><surname>King</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Primary diffuse large B cell lymphoma of the common bile duct</article-title><source>J Gastrointest Surg</source><year>2020</year><volume>24</volume><fpage>2376</fpage><lpage>2378</lpage><pub-id pub-id-type="doi">10.1007/s11605-020-04569-8</pub-id><pub-id pub-id-type="pmid">32193846</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Wong DL, Deschner BW, King LC, et al. Primary diffuse large B cell lymphoma of the common bile duct. J Gastrointest Surg. 2020;24:2376&#x02013;8.<pub-id pub-id-type="pmid">32193846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Hans</surname><given-names>CP</given-names></name><name><surname>Weisenburger</surname><given-names>DD</given-names></name><name><surname>Greiner</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray</article-title><source>Blood</source><year>2004</year><volume>103</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-05-1545</pub-id><pub-id pub-id-type="pmid">14504078</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275&#x02013;82.<pub-id pub-id-type="pmid">14504078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>LS</given-names></name><name><surname>Hancock</surname><given-names>BW</given-names></name></person-group><article-title>Non-Hodgkin lymphoma</article-title><source>Lancet</source><year>2003</year><volume>362</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(03)13868-8</pub-id><pub-id pub-id-type="pmid">12867117</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2003;362:139&#x02013;46.<pub-id pub-id-type="pmid">12867117</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>GK</given-names></name></person-group><article-title>Primary extranodal non-Hodgkin&#x02019;s lymphoma of the extrahepatic bile. Report of a case</article-title><source>Cancer</source><year>1982</year><volume>50</volume><fpage>2218</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.1002/1097-0142(19821115)50:10&#x0003c;2218::AID-CNCR2820501041&#x0003e;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">7127262</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Nguyen GK. Primary extranodal non-Hodgkin&#x02019;s lymphoma of the extrahepatic bile. Report of a case. Cancer. 1982;50:2218&#x02013;22.<pub-id pub-id-type="pmid">7127262</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtsubo</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name><name><surname>Yanagimura</surname><given-names>N</given-names></name><etal/></person-group><article-title>Multiple malignant lymphomas of the bile duct developing after spontaneous regression of an autoimmune pancreatitis-like Mass</article-title><source>Intern Med</source><year>2021</year><volume>60</volume><fpage>409</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.5429-20</pub-id><pub-id pub-id-type="pmid">32863365</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Ohtsubo K, Yamashita K, Yanagimura N, et al. Multiple malignant lymphomas of the bile duct developing after spontaneous regression of an autoimmune pancreatitis-like Mass. Intern Med. 2021;60:409&#x02013;15.<pub-id pub-id-type="pmid">32863365</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Sekine</surname><given-names>M</given-names></name><name><surname>Aoyama</surname><given-names>K</given-names></name><etal/></person-group><article-title>Primary bile duct diffuse large B-cell lymphoma diagnosed by repeated endoscopic ultrasound-guided fine-needle aspiration and endoscopic retrograde cholangiopancreatography</article-title><source>Intern Med</source><year>2024</year><volume>63</volume><fpage>493</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.1776-23</pub-id><pub-id pub-id-type="pmid">37344437</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Imai Y, Sekine M, Aoyama K, et al. Primary bile duct diffuse large B-cell lymphoma diagnosed by repeated endoscopic ultrasound-guided fine-needle aspiration and endoscopic retrograde cholangiopancreatography. Intern Med. 2024;63:493&#x02013;501.<pub-id pub-id-type="pmid">37344437</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Durham</surname><given-names>C</given-names></name><name><surname>Jaiswal</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>L</given-names></name></person-group><article-title>Bile duct lymphoma disguised as cholangiocarcinoma</article-title><source>Proc (Bayl Univ Med Cent)</source><year>2017</year><volume>30</volume><fpage>190</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">28405078</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Durham C, Jaiswal D, Wong L. Bile duct lymphoma disguised as cholangiocarcinoma. Proc (Bayl Univ Med Cent). 2017;30:190&#x02013;1.<pub-id pub-id-type="pmid">28405078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Corbinais</surname><given-names>S</given-names></name><name><surname>Caulet-Maugendre</surname><given-names>S</given-names></name><name><surname>Pagenault</surname><given-names>M</given-names></name><etal/></person-group><article-title>Primary T-cell lymphoma of the common bile duct</article-title><source>Gastroenterol Clin Biol</source><year>2000</year><volume>24</volume><fpage>843</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">11011261</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Corbinais S, Caulet-Maugendre S, Pagenault M, et al. Primary T-cell lymphoma of the common bile duct. Gastroenterol Clin Biol. 2000;24:843&#x02013;7 (<bold>(in French)</bold>).<pub-id pub-id-type="pmid">11011261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>K</given-names></name><name><surname>Fisher</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Primary non-Hodgkin&#x02019;s lymphoma of the bile ducts mimicking cholangiocarcinoma</article-title><source>Surgery</source><year>2003</year><volume>134</volume><fpage>496</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1067/S0039-6060(03)00149-1</pub-id><pub-id pub-id-type="pmid">14555939</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Das K, Fisher A, Wilson DJ, et al. Primary non-Hodgkin&#x02019;s lymphoma of the bile ducts mimicking cholangiocarcinoma. Surgery. 2003;134:496&#x02013;500.<pub-id pub-id-type="pmid">14555939</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Torrealba M, Berzosa M, Raijman I. Single-operator cholangioscopy for the diagnosis of bile duct lymphoma: a case report and brief review of the literature. Endoscopy. 2013;45 Supplement 2 UCTN:E359&#x02013;60.</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Ikuta</surname><given-names>R</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><etal/></person-group><article-title>A case of obstructive jaundice caused by MALT lymphoma of the common bile duct and the papilla of Vater</article-title><source>Nihon Shokakibyo Gakkai Zasshi</source><year>2015</year><volume>112</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">25748157</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Ikuta R, Ueda M, Yamamoto T, et al. A case of obstructive jaundice caused by MALT lymphoma of the common bile duct and the papilla of Vater. Nihon Shokakibyo Gakkai Zasshi. 2015;112:307&#x02013;16 (<bold>(in Japanese)</bold>).<pub-id pub-id-type="pmid">25748157</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Okita</surname><given-names>M</given-names></name><etal/></person-group><article-title>A case of mucosa-associated lymphoid tissue lymphoma of the bile duct diagnosed using intraductal ultrasonography and transpapillary investigation of the bile duct</article-title><source>Nihon Shokakibyo Gakkai Zasshi</source><year>2020</year><volume>117</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">32281576</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Inoue S, Takeda K, Okita M, et al. A case of mucosa-associated lymphoid tissue lymphoma of the bile duct diagnosed using intraductal ultrasonography and transpapillary investigation of the bile duct. Nihon Shokakibyo Gakkai Zasshi. 2020;117:345&#x02013;53 (<bold>(in Japanese)</bold>).<pub-id pub-id-type="pmid">32281576</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Pararas</surname><given-names>N</given-names></name><name><surname>Foukas</surname><given-names>PG</given-names></name><name><surname>Pikoulis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: a case report</article-title><source>Mol Clin Oncol</source><year>2022</year><volume>17</volume><fpage>115</fpage><pub-id pub-id-type="doi">10.3892/mco.2022.2548</pub-id><pub-id pub-id-type="pmid">35747593</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Pararas N, Foukas PG, Pikoulis A, et al. Primary non-Hodgkin lymphoma of the extra-hepatic bile duct: a case report. Mol Clin Oncol. 2022;17:115.<pub-id pub-id-type="pmid">35747593</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Tsujie</surname><given-names>M</given-names></name><name><surname>Wakasa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Primary diffuse large B cell lymphoma of the common bile duct causing obstructive jaundice</article-title><source>Int Canc Conf J</source><year>2016</year><volume>5</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1007/s13691-015-0238-2</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Kato H, Tsujie M, Wakasa T, et al. Primary diffuse large B cell lymphoma of the common bile duct causing obstructive jaundice. Int Canc Conf J. 2016;5:107&#x02013;12.</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Yanai</surname><given-names>S</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical classifications for diagnosis and treatment for gastric lymphomas</article-title><source>Stomach Intestine</source><year>2017</year><volume>52</volume><fpage>45</fpage><lpage>52</lpage></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Nakamura S, Yanai S, Kawasaki K, et al. Clinical classifications for diagnosis and treatment for gastric lymphomas. Stomach Intestine. 2017;52:45&#x02013;52 (<bold>(in Japanese)</bold>).</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Ohhashi</surname><given-names>S</given-names></name><name><surname>Miyahara</surname><given-names>R</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><etal/></person-group><source>Stomach and intestine</source><year>2006</year><volume>41</volume><fpage>315</fpage><lpage>322</lpage></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Ohhashi S, Miyahara R, Matsuura T, et al. Stomach and intestine. 2006;41:315&#x02013;22 (<bold>(in Japanese)</bold>).</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>Y</given-names></name><name><surname>Serikawa</surname><given-names>M</given-names></name><name><surname>Tsuboi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Usefulness of peroral cholangioscopy in the differential diagnosis of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma: a single-center retrospective study</article-title><source>BMC Gastroenterol</source><year>2020</year><volume>20</volume><fpage>287</fpage><pub-id pub-id-type="doi">10.1186/s12876-020-01429-2</pub-id><pub-id pub-id-type="pmid">32831026</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Ishii Y, Serikawa M, Tsuboi T, et al. Usefulness of peroral cholangioscopy in the differential diagnosis of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma: a single-center retrospective study. BMC Gastroenterol. 2020;20:287.<pub-id pub-id-type="pmid">32831026</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Osanai</surname><given-names>M</given-names></name><name><surname>Itoi</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Peroral video cholangioscopy to evaluate indeterminate bile duct lesions and preoperative mucosal cancerous extension: a prospective multicenter study</article-title><source>Endoscopy</source><year>2013</year><volume>45</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1326631</pub-id><pub-id pub-id-type="pmid">23807803</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Osanai M, Itoi T, Igarashi Y, et al. Peroral video cholangioscopy to evaluate indeterminate bile duct lesions and preoperative mucosal cancerous extension: a prospective multicenter study. Endoscopy. 2013;45:635&#x02013;42.<pub-id pub-id-type="pmid">23807803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Itoi</surname><given-names>T</given-names></name><name><surname>Kamisawa</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis</article-title><source>J Gastroenterol</source><year>2013</year><volume>48</volume><fpage>504</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1007/s00535-012-0652-6</pub-id><pub-id pub-id-type="pmid">22948487</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Itoi T, Kamisawa T, Igarashi Y, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol. 2013;48:504&#x02013;14.<pub-id pub-id-type="pmid">22948487</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii-Lau</surname><given-names>LL</given-names></name><name><surname>Thosani</surname><given-names>NC</given-names></name><name><surname>Al-Haddad</surname><given-names>M</given-names></name><etal/></person-group><article-title>American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: Summary and recommendations</article-title><source>Gastrointest Endosc</source><year>2023</year><volume>98</volume><fpage>685</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1016/j.gie.2023.06.005</pub-id><pub-id pub-id-type="pmid">37307900</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Fujii-Lau LL, Thosani NC, Al-Haddad M, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the diagnosis of malignancy in biliary strictures of undetermined etiology: Summary and recommendations. Gastrointest Endosc. 2023;98:685&#x02013;93.<pub-id pub-id-type="pmid">37307900</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>NS</given-names></name><name><surname>Trindade</surname><given-names>AJ</given-names></name><name><surname>Sejpal</surname><given-names>DV</given-names></name></person-group><article-title>Determining the indeterminate biliary stricture: Cholangioscopy and beyond</article-title><source>Curr Gastroenterol Rep</source><year>2020</year><volume>22</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1007/s11894-020-00797-9</pub-id><pub-id pub-id-type="pmid">33141356</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Martinez NS, Trindade AJ, Sejpal DV. Determining the indeterminate biliary stricture: Cholangioscopy and beyond. Curr Gastroenterol Rep. 2020;22:58.<pub-id pub-id-type="pmid">33141356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakahara</surname><given-names>O</given-names></name><name><surname>Yamao</surname><given-names>K</given-names></name><name><surname>Bhatia</surname><given-names>V</given-names></name><etal/></person-group><article-title>Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy</article-title><source>J Gastroenterol</source><year>2009</year><volume>44</volume><fpage>562</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1007/s00535-009-0048-4</pub-id><pub-id pub-id-type="pmid">19360372</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Nakahara O, Yamao K, Bhatia V, et al. Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy. J Gastroenterol. 2009;44:562&#x02013;7.<pub-id pub-id-type="pmid">19360372</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Davidson</surname><given-names>BR</given-names></name><name><surname>Goldin</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update</article-title><source>Gut</source><year>2012</year><volume>61</volume><fpage>1657</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2011-301748</pub-id><pub-id pub-id-type="pmid">22895392</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657&#x02013;69.<pub-id pub-id-type="pmid">22895392</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>